Saltar al contenido
Merck

Heterozygous variants in TBCK cause a mild neurologic syndrome in humans and mice.

American journal of medical genetics. Part A (2023-06-24)
Divya Nair, Abdias Diaz-Rosado, Elisa Varella-Branco, Igor Ramos, Aaron Black, Rajesh Angireddy, Joseph Park, Svathi Murali, Andrew Yoon, Brianna Ciesielski, W Timothy O'Brien, Maria Rita Passos-Bueno, Elizabeth Bhoj
RESUMEN

TBCK-related encephalopathy is a rare pediatric neurodegenerative disorder caused by biallelic loss-of-function variants in the TBCK gene. After receiving anecdotal reports of neurologic phenotypes in both human and mouse TBCK heterozygotes, we quantified if TBCK haploinsufficiency causes a phenotype in mice and humans. Using the tbck+/- mouse model, we performed a battery of behavioral assays and mTOR pathway analysis to investigate potential alterations in neurophysiology. We conducted as well a phenome-wide association study (PheWAS) analysis in a large adult biobank to determine the presence of potential phenotypes associated to this variant. The tbck+/- mouse model demonstrates a reduction of exploratory behavior in animals with significant sex and genotype interactions. The concurrent PheWAS analysis of 10,900 unrelated individuals showed that patients with one copy of a TBCK loss-of-function allele had a significantly higher rate of acquired toe and foot deformities, likely indicative of a mild peripheral neuropathy phenotype. This study presents an example of what may be the underappreciated occurrence of mild neurogenic symptoms in heterozygote individuals of recessive neurogenetic syndromes.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-LC3 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-TBCK antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution